The Organisation of European Cancer Institute (OECI) accreditation programme focuses on multidisciplinary and integrated cancer treatment and cancer research.

Read more about the accreditation programme:

Home - OECI - Accreditation

• To identify strengths and weaknesses in the treatment of patients with cancer to further develop safe and comprehensive patient pathways of the highest standards
• To strengthen internal collaboration at AUH and improve collaboration on joint cancer pathways across the hospitals in Central Denmark Region
• To strengthen the collaboration between AUH and Aarhus University through a committed and focused research collaboration within the field of cancer
• To participate in and increase European collaborations in relation to cancer research in particular

The entire accreditation process lasts about 18 months including a self-evaluation process (collecting data and drafting documentation) and a 2-day audit by the OECI.

The accreditation process started with the self-evaluation process in January 2024. In April 2025, AUH expects the planned audit by the OECI who will review data and documentation as well as interview staff at various departments across the hospital.

After the audit, AUH will draft an improvement plan with action plans, which will guide the work to take place between re-accreditations, which take place every fifth year.

One year after certification, the OECI will follow-up on our improvement and action plans, to maintain a systematic and ongoing focus on quality and improvement.

AUH’s ambitions in the field of cancer

The accreditation as a CCC is an important element in the development and strategic ambitions of AUH.

The accreditation will contribute with:

• Improved cancer treatment
  The accreditation will identify strengths and weaknesses in cancer treatment, which can lead to higher treatment standards and improved patient pathways, which on a longer term may contribute to develop more safe and complete cancer pathways
• Efficiency and better use of resources
  The accreditation can contribute to promoting value-creating collaboration, coordination and exchange of experiences about multidisciplinary patient pathways, which will result in more coherent, holistic and efficient pathways. Relevant standards across the hospital will be emphasised, creating synergies between the field of cancer and other specialties.
• Transformation of healthcare
  An accreditation as a CCC will contribute to quality assurance of the field of cancer at AUH. Accreditation is a part of the transformation and prioritisation agenda in Central Denmark Region to support an evidence-based healthcare system. Accreditation must be integrated in current practices to ensure meaningfulness and value-creation of the accreditation programme.

Accreditation can also strengthen the reputation of the hospital as a leading cancer hospital, both nationally and internationally.

Cancer Strategy 2025-2027

Aarhus CCC has drafted a Cancer Strategy 2025-2027 with four strategic tracks and focus areas:

•  Patient-centred focus
• Professional development
• Quality and data
• Research

Read the Cancer Strategy (pdf)

Strategy for Cancer Research 2025-2027

Aarhus CCC has drafted a Strategy for Cancer Research 2025-2027, where the research ambition for 2025-2027 is to create the best conditions for further targeted strategic development of cancer research.

Read the Cancer Research Strategy (pdf)

EU ambitions in the field of cancer

The goal of the EU Commission is that 90% of all patients with cancer in the EU will have access to CCC accredited centres/hospitals in 2030. In 2025, the EU Commission will establish a new EU network of CCC accredited cancer centres connecting national CCCs in each EU member state. AUH participates in the EU network.

Read more about EUs Cancer Plan